Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Grant Ellsworth, MD, MS
Weill Medical College of Cornell University
Principal Investigator - Timothy Wilkin, MD, MPH
University of California, San Diego
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Puerto Rico
San Juan, Puerto Rico
Carmen D Zorilla, MDJorge Santana-Bagur, MD
- Weill Cornell Medical College
New York, New York, United States
Grant Ellsworth, MD, MS - Montefiore Medical Center/albert Einstein College of Medicine
The Bronx, New York, United States
Mark H Einstein, MD, MS
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Oct 2025
- Primary completion
- 31 Jul 2026
- Completion
- 31 Jul 2026
- Last update posted
- 1 Oct 2025
- Registered enrollment
- 27
- Registry id
- NCT07090174
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.